Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation by longitudeadmin | Nov 14, 2013 | Portfolio News
Civitas Therapeutics Extends CVT-301 Patent Protection into 2032 by longitudeadmin | Nov 8, 2013 | Portfolio News
Onset Dermatologics, LLC Acquires Worldwide Rights to Clindagel (clindamycin phosphate gel) topical gel, 1% from Galderma Laboratories by longitudeadmin | Oct 30, 2013 | Portfolio News
“Challenges of Treating Patients with Chronic Pain with Dysphagia (CPD): Physician and Patient Perspectives,” Published in Peer-Reviewed Medical Journal by longitudeadmin | Oct 29, 2013 | Portfolio News
CardioDx Real-World Registry Study Shows Use of the Corus® CAD Gene Expression Test Helps Reduce Unnecessary Patient Referrals for Cardiac Testing by longitudeadmin | Oct 21, 2013 | Portfolio News
